Medicare Advantage Compliance Failures: What Happened After Somebody Noticed

Medicare Advantage compliance failures can begin after the audit works. The Medicare Advantage fraud complaints below describe coding teams finding unsupported diagnoses, management receiving the warning, and payment practices continuing. A useful control disappears. A correction loses to a revenue target. Somebody noticed. The question is what happened next.

The allegations make the decision to overrule compliance concrete. They put the audit beside the response, the vendor’s fee beside the coding decision, and the warning beside the next submission. That is where an insider may recognize the business they work in.

Why the Correction Changes the Revenue

Removing an unsupported diagnosis can lower the plan’s Medicare payment. Medicare pays a private plan a monthly amount for each enrollee, adjusted for expected health care costs. Diagnosis codes help determine the risk score, and a higher score raises the payment. When unsupported codes raise that payment, taxpayers pay for illness the chart does not support.

The money can reach the provider group, too. In Medicare Advantage Fraud, Waste, and Abuse Policy Options, the American Institutes for Research explains how a provider paid through a share of the plan’s premium can benefit from higher diagnosis-based payments: when coding intensity pushes up Medicare’s payment to the plan, a percentage-of-premium arrangement pushes up the provider’s revenue with it.

The report also describes how ownership ties can give a plan more influence over provider coding through chart reviews, documentation incentives and prompts in medical records. The person checking a diagnosis and the person budgeting its revenue can be looking at the same chart for very different reasons.

What the Complaints Say Happened Next

Kaiser Permanente: A Working Control Switched Off

Kaiser Permanente allegedly built a correction, measured its success and then dismantled it. The Colorado whistleblower’s complaint describes a cancer-coding audit that led Kaiser to delete unsupported claims and refund Medicare.

The complaint describes a medical-record alert reminding physicians to distinguish active cancer from a history of cancer. According to the complaint, coding accuracy rose to 96% for breast cancer and 93% for prostate cancer. It alleges that in 2010, Kaiser turned the alert off and replaced it with a limited filter. In late 2011 or early 2012, it turned that filter off to save money and coding resources. The complaint says the error rate rebounded.

That sequence gives the allegation its force. The organization had the finding, the fix and a measurement showing that the fix worked.

A separate Kaiser complaint describes disputed aortic atherosclerosis coding continuing while the national compliance office considered it. When that office finally rejected the blanket coding direction in August 2015, the complaint says there was no plan to address the inaccurate codes already submitted. Changing the instruction left the earlier payment problem unresolved.

The Justice Department’s January 2026 settlement announcement records Kaiser’s agreement to pay $556 million to resolve allegations of submitting invalid diagnosis codes for higher Medicare Advantage payments.

Group Health Cooperative: The Coding Team Bypassed

According to its whistleblower complaint, Group Health Cooperative had a coding department that had challenged a previous vendor’s submissions. The filing alleges that leadership directed the next vendor, DxID, to send its submission-ready file through finance instead. The department that could question the codes no longer stood in their way.

The complaint says the whistleblower and a physician reviewed the new codes and concluded that 74% lacked sufficient documentation. It says management’s concern was that Group Health had paid DxID for codes already submitted, rather than the accuracy of the new claims. Management authorized only a limited set for reconsideration.

The government’s later complaint alleges that Group Health paid DxID 20% of the additional revenue. It also describes a diagnosis of alcohol dependence drawn from an old entry marked resolved. A condition could be over in the medical record and still valuable in the payment file.

Group Health, by then named Kaiser Foundation Health Plan of Washington, agreed to pay $6,375,000 to resolve allegations of invalid diagnoses and inflated Medicare payments.

Martin’s Point: The Revenue Goal Won

Martin’s Point Health Care allegedly gave reviewers a revenue target that correcting errors would undermine. Its whistleblower described a one-way chart review process in which staff could see erroneous codes but were directed to add diagnoses that generated revenue.

The complaint states the choice plainly:

The same filing alleges that finance set risk-score targets below the level expected to trigger a CMS audit, and that staff beginning quality-assurance work were reassigned to meet revenue goals. The correction had an owner and a purpose. It lost to the budget.

Martin’s Point later agreed to pay $22,485,000 to resolve the government’s allegations of inaccurate diagnosis submissions.

Sutter Health: The Auditors Audited

Sutter Health allegedly answered an audit finding by examining the people who produced it. The whistleblower’s complaint describes concerns about cancer, fracture and stroke coding, followed by instructions to stop auditing.

According to the complaint, the compliance department reviewed five encounters from the audit team’s work, found three auditing errors and declared the whistleblower’s compliance concerns unfounded. A review took place. Its subject had changed from the questionable diagnoses to the auditors who questioned them.

Sutter’s 2021 agreement to pay $90 million resolved allegations of knowingly submitting inaccurate information about Medicare Advantage patients’ health status.

Seoul Medical Group: The Auditor Became a Subsidiary

Seoul Medical Group allegedly refused its management company’s correction plan and then acquired the company. According to the whistleblower’s complaint, Advanced Medical Management reviewed patient charts and estimated more than $6.7 million in overpayments from unsupported diagnoses. It supplied a plan and a timetable for withdrawing the codes.

The complaint says Seoul refused the correction and purchased Advanced Medical Management in June 2018. It alleges that the acquisition and subsequent changes to personnel were intended to prevent correction and withdrawal of unsupported codes. It also alleges that Seoul later refused to let the management company audit charts prepared by Seoul’s board members.

In the complaint’s account, the watchdog became a subsidiary of the business it had challenged.

The Justice Department’s 2025 settlement announcement records a $58,740,000 agreement by Seoul and Advanced Medical Management over alleged false spinal diagnoses.

MedXM: The Coders Were in the Building

MedXM allegedly employed certified medical coders while assigning diabetic retinopathy eye-exam coding to its data-processing staff. The whistleblowers’ complaint says those staff received a list of positive-result codes and instructions to choose the closest match to the examiner’s notes. Requests for coding training were refused.

The complaint alleges MedXM made no effort to review, audit or correct that eye-exam coding. It describes an employee repeatedly raising the coding problem with supervisors and asking the coding department for training and oversight. The department with the expertise was there. According to the complaint, it declined to provide that oversight.

eHealth: A Sales Warning Repeated

The government’s complaint against eHealth and other insurance brokers describes a different channel: broker payments and enrollment decisions. In its account of Aetna, the issue was pressure to reduce enrollment by Medicare beneficiaries with disabilities.

The complaint quotes an internal warning against asking sales partners to reduce those enrollments. It says the pressure continued. When the subject returned in January 2021, an Aetna executive answered:

The warning came from inside the insurer. In the government’s account, it did not settle the question for the people directing sales. A compliance failure could shape who got enrolled before any diagnosis reached a payment file.

DaVita: A Laboratory Parallel

DaVita’s laboratory case shows the same choice outside Medicare Advantage diagnosis coding. The Florida whistleblowers’ complaint alleges that senior leadership received repeated concerns about specimen stability and test validation. For peritoneal dialysate testing, it describes an explicit response: leadership decided to continue testing despite the reported lack of validation. A technical warning reached the people who could act on it. According to the complaint, they kept the testing going.

What Outside Oversight Adds

The Department of Health and Human Services’ Office of Inspector General estimated in its October 2024 evaluation of health risk assessments that diagnoses found only on assessments or their linked chart reviews generated $7.5 billion in Medicare Advantage payments for 2023. Those diagnoses appeared on no other service records in the data examined.

The Inspector General identified a healthcare problem as well as a payment problem: either the diagnoses were inaccurate and the payments improper, or enrollees had serious conditions without the needed follow-up care. The report recommended restrictions, validation through representative or targeted samples of diagnoses, and closer examination of conditions vulnerable to misuse.

Access controls deserve the same attention. In its June 2026 review of post-hospital authorization decisions, the Inspector General found that contractors drove high denial rates in some cases, with many decisions later overturned by the plan. It called for data identifying the service and contractor, and examination of the reasons for variation. Oversight has to reach the decisions a vendor makes.

The Rules Are Moving Toward the Same Files

The Inspector General’s 2026 Medicare Advantage compliance guidance identifies failure to remove unsupported codes, in-home assessments disconnected from care, and physician prompts for unsupported diagnoses as areas of concern.

The Centers for Medicare & Medicaid Services’ 2027 payment announcement goes further on which diagnoses count. For that payment year, it excludes diagnoses from unlinked chart-review records, with an exception for beneficiaries switching Medicare Advantage organizations, and excludes diagnoses from audio-only services.

The Finding and the Decision Belong Together

These complaints make the response to a warning part of the story: the alert removed after it worked, the submission routed through finance, the deletion process rejected, the auditor brought under the audited company’s control. The useful evidence connects what the organization learned to what it continued to submit, pay or approve.

What is rare in these documents is not the noticing. It is the acting.

When You Have the Finding and the Response

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. If you work in coding, compliance, finance or a vendor team and watched a documented problem survive its own review, speak to one of our whistleblower experts about the finding nobody acted on. We work with you to build your strongest Medicare Advantage whistleblower case around those decisions, bring in Medicare Advantage whistleblower lawyers who know risk adjustment and compliance, and stay beside you through the case.